BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29268937)

  • 1. Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study).
    Fretz A; McEvoy JW; Rebholz CM; Ndumele CE; Florido R; Hoogeveen RC; Ballantyne CM; Selvin E
    Am J Cardiol; 2018 Feb; 121(4):430-436. PubMed ID: 29268937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.
    McEvoy JW; Lazo M; Chen Y; Shen L; Nambi V; Hoogeveen RC; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    Int J Cardiol; 2015; 187():651-7. PubMed ID: 25880403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Sensitivity Cardiac Troponin T and Risk of Hypertension.
    McEvoy JW; Chen Y; Nambi V; Ballantyne CM; Sharrett AR; Appel LJ; Post WS; Blumenthal RS; Matsushita K; Selvin E
    Circulation; 2015 Sep; 132(9):825-33. PubMed ID: 26152706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-year change in high sensitivity cardiac troponin T and the risk of atrial fibrillation in the Atherosclerosis Risk in Communities cohort.
    Li L; Selvin E; Hoogeveen RC; Soliman EZ; Chen LY; Norby FL; Alonso A
    Clin Cardiol; 2021 Nov; 44(11):1594-1601. PubMed ID: 34545585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
    Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
    Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.
    Lazo M; Chen Y; McEvoy JW; Ndumele C; Konety S; Ballantyne CM; Sharrett AR; Selvin E
    Clin Chem; 2016 Sep; 62(9):1202-10. PubMed ID: 27440513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
    Whelton SP; McEvoy JW; Lazo M; Coresh J; Ballantyne CM; Selvin E
    Diabetes Care; 2017 Feb; 40(2):261-269. PubMed ID: 28108537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
    Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
    Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
    J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population.
    Rubin J; Matsushita K; Lazo M; Ballantyne CM; Nambi V; Hoogeveen R; Sharrett AR; Blumenthal RS; Coresh J; Selvin E
    Clin Biochem; 2016 Jun; 49(9):657-662. PubMed ID: 26975902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
    Myhre PL; Claggett B; Ballantyne CM; Selvin E; Røsjø H; Omland T; Solomon SD; Skali H; Shah AM
    JAMA Cardiol; 2019 Oct; 4(10):997-1006. PubMed ID: 31483438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.
    Divard G; Abbas R; Chenevier-Gobeaux C; Chanson N; Escoubet B; Chauveheid MP; Dossier A; Papo T; Dehoux M; Sacre K
    Arthritis Res Ther; 2017 Jun; 19(1):132. PubMed ID: 28610589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, subclinical myocardial injury, and incident heart failure.
    Ndumele CE; Coresh J; Lazo M; Hoogeveen RC; Blumenthal RS; Folsom AR; Selvin E; Ballantyne CM; Nambi V
    JACC Heart Fail; 2014 Dec; 2(6):600-7. PubMed ID: 25443112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC).
    Hamo CE; Echouffo-Tcheugui JB; Zhang S; Florido R; Pankow JS; Michos ED; Goldberg R; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne C; Selvin E; Coresh J; Ndumele CE
    Clin Chem; 2022 Oct; 68(10):1272-1280. PubMed ID: 35904048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Heart Association's Life's Simple 7 at Middle Age and Prognosis After Myocardial Infarction in Later Life.
    Mok Y; Sang Y; Ballew SH; Rebholz CM; Rosamond WD; Heiss G; Folsom AR; Coresh J; Matsushita K
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29455158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical Activity, Obesity, and Subclinical Myocardial Damage.
    Florido R; Ndumele CE; Kwak L; Pang Y; Matsushita K; Schrack JA; Lazo M; Nambi V; Blumenthal RS; Folsom AR; Coresh J; Ballantyne CM; Selvin E
    JACC Heart Fail; 2017 May; 5(5):377-384. PubMed ID: 28449797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
    McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).
    Seliger SL; Hong SN; Christenson RH; Kronmal R; Daniels LB; Lima JAC; de Lemos JA; Bertoni A; deFilippi CR
    Circulation; 2017 Apr; 135(16):1494-1505. PubMed ID: 28159799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.